Bank of New York Mellon’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.8M Sell
592,821
-5,568
-0.9% -$45K ﹤0.01% 2277
2025
Q1
$5.01M Sell
598,389
-25,449
-4% -$213K ﹤0.01% 2210
2024
Q4
$4.94M Sell
623,838
-894
-0.1% -$7.08K ﹤0.01% 2294
2024
Q3
$5.2M Sell
624,732
-126,671
-17% -$1.05M ﹤0.01% 2274
2024
Q2
$4.77M Buy
751,403
+128,772
+21% +$818K ﹤0.01% 2371
2024
Q1
$3.77M Sell
622,631
-12,883
-2% -$78.1K ﹤0.01% 2451
2023
Q4
$3.86M Sell
635,514
-52,848
-8% -$321K ﹤0.01% 2495
2023
Q3
$2.9M Buy
688,362
+60,024
+10% +$253K ﹤0.01% 2592
2023
Q2
$1.95M Buy
628,338
+165,137
+36% +$512K ﹤0.01% 2851
2023
Q1
$644K Sell
463,201
-24,162
-5% -$33.6K ﹤0.01% 3352
2022
Q4
$970K Sell
487,363
-100,493
-17% -$200K ﹤0.01% 3205
2022
Q3
$1.19M Buy
587,856
+48,526
+9% +$98.1K ﹤0.01% 3117
2022
Q2
$1.72M Sell
539,330
-27,007
-5% -$85.9K ﹤0.01% 2917
2022
Q1
$2.36M Buy
566,337
+6,097
+1% +$25.4K ﹤0.01% 2835
2021
Q4
$2.68M Sell
560,240
-24,603
-4% -$118K ﹤0.01% 2812
2021
Q3
$3.12M Buy
584,843
+31,095
+6% +$166K ﹤0.01% 2745
2021
Q2
$2.84M Sell
553,748
-85,795
-13% -$439K ﹤0.01% 2781
2021
Q1
$4.3M Sell
639,543
-135,277
-17% -$910K ﹤0.01% 2504
2020
Q4
$3.54M Sell
774,820
-223,226
-22% -$1.02M ﹤0.01% 2524
2020
Q3
$3.87M Sell
998,046
-54,726
-5% -$212K ﹤0.01% 2352
2020
Q2
$5.01M Sell
1,052,772
-200,237
-16% -$953K ﹤0.01% 2205
2020
Q1
$4.36M Sell
1,253,009
-69,407
-5% -$242K ﹤0.01% 2139
2019
Q4
$6.37M Buy
1,322,416
+787,166
+147% +$3.79M ﹤0.01% 2216
2019
Q3
$1.55M Buy
535,250
+33,842
+7% +$98.1K ﹤0.01% 2894
2019
Q2
$3.6M Buy
501,408
+15,435
+3% +$111K ﹤0.01% 2493
2019
Q1
$6.89M Buy
485,973
+45,174
+10% +$640K ﹤0.01% 2178
2018
Q4
$5.96M Sell
440,799
-53,736
-11% -$727K ﹤0.01% 2188
2018
Q3
$11M Buy
494,535
+27,206
+6% +$604K ﹤0.01% 1964
2018
Q2
$7.67M Buy
+467,329
New +$7.67M ﹤0.01% 2167